20 January 2023 (Friday) - Transfusion News Update

The nice people at Transfusion News sent their update today… convalescent plasma *is* worth having… this week.

 

Plasmapheresis Associated with Reduced Mortality Among Patients with Severe COVID-19

January 18, 2023 Over 6 million people have died due to COVID-19 worldwide since the start of the pandemic. Several comorbidities are associated with COVID-19 disease severity, such as older age, obesity, cardiovascular disease, cancer, and other conditions that weaken the immune system. [Read more]

RESTORE Trial (REcovery and Survival of Stem cell Originated Rd cells)

Join Transfusion News Associate Editors Daniela Hermelin and Monica Pagano on Twitter Space this Friday January 20 at 11:00 AM ET for a #Blooducation Baristas live event. They will discuss the RESTORE Trial along with lead investigators Cedric Ghevaert, Ash Toye and Rebecca Cardigan. [Set a reminder to join us]

COVID-19 Convalescent Plasma Improves Outcomes for Cancer Patients

January 10, 2023 Standard COVID-19 therapies and vaccines have limited effectiveness in patients with impaired humoral immune responses, and these patients have a high risk of severe COVID-19. High titer COVID-19 convalescent plasma (CCP) used early in the disease has been shown to reduce the risk of hospitalization among immunocompetent outpatients. [Read more]